Clinical Radiology
Volume 62, Issue 1 , Pages 35-36 , January 2007

Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis

  • S. Swift

      Affiliations

    • Corresponding Author InformationGuarantor and correspondent: S. Swift, Department of Radiology, St James's and Cookridge Hospitals, Leeds, UK. Tel.: +1 13 2065461; fax: +1 13 2066364.

Received 7 July 2006 ,Accepted 31 July 2006.

References 

  1. Hricak H, Mendelson E, Bohm-Velez M, et al. Endometrial cancer of the uterus. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000;215(Suppl):947–953
  2. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999;212:711–718
  3. Frei K, Kinkel K, Bonel HM, et al. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and bayesian analysis. Radiology. 2000;216:444–449
  4. Recommendations for Cross-Sectional Imaging in Cancer Management. London: RCR; 2006.
  5. Sohaib SA, Houghton SL, Meroni R, et al. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol. 2007;62:28–34
  6. Fleming GF. Major progress for a less common cancer. J Clin Oncol. 2006;24:6–8
  7. Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology study. J Clin Oncol. 2006;24:36–44
  8. Vaidya AP, Littell R, Krasner C, et al. Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel. Int J Gynecol Cancer. 2006;16:267–272
  9. Sartori E, Laface B, Gadducci A, et al. Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force study. Int J Gynecol Cancer. 2003;13:458–465
  10. Tjalma WAA, Van Dam PA, Makar AP, et al. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int J Gynecol Cancer. 2004;14:931–937
  11. Belhocine T, De Barsy C, Hustinx R, et al. Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging. 2002;29:1132–1139

PII: S0009-9260(06)00275-3

doi: 10.1016/j.crad.2006.07.010

Clinical Radiology
Volume 62, Issue 1 , Pages 35-36 , January 2007

Article Tools